These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37810148)

  • 1. Examining the impact of university-industry collaborations on spin-off creation: Evidence from joint patents.
    Martínez-Ardila H; Castro-Rodriguez Á; Camacho-Pico J
    Heliyon; 2023 Sep; 9(9):e19533. PubMed ID: 37810148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry-university collaborations in Canada, Japan, the UK and USA--with emphasis on publication freedom and managing the intellectual property lock-up problem.
    Kneller R; Mongeon M; Cope J; Garner C; Ternouth P
    PLoS One; 2014; 9(3):e90302. PubMed ID: 24632805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing university-business collaborations for moderate innovators: Implications for university-led innovation policy evaluation.
    Marra M; Alfano V; Celentano RM
    Eval Program Plann; 2022 Dec; 95():102170. PubMed ID: 36202045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Spin-Offs Make the Academics' Heads Spin?: The Impacts of Spin-Off Companies on Their Parent Research Organisation.
    Zomer AH; Jongbloed BW; Enders J
    Minerva; 2010 Sep; 48(3):331-353. PubMed ID: 20936164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Values in University-Industry Collaborations: The Case of Academics Working at Universities of Technology.
    Hillerbrand R; Werker C
    Sci Eng Ethics; 2019 Dec; 25(6):1633-1656. PubMed ID: 31620956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Productive interactions in digital training partnerships: Lessons learned for regional development and university societal impact assessment.
    Marra M
    Eval Program Plann; 2022 Dec; 95():102173. PubMed ID: 36198227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical innovation and institutional interdependence: rethinking university-industry connections.
    Gelijns AC; Thier SO
    JAMA; 2002 Jan; 287(1):72-7. PubMed ID: 11754711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovation by coercion: Emerging institutionalization of university-industry collaborations in Russia.
    Bychkova O
    Soc Stud Sci; 2016 Aug; 46(4):511-535. PubMed ID: 28948870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?
    Dhainaut JF; Blin O; Herry F; ; Benito S; Bilbault P; Cauterman M; Favrel-Feuillade F; Fazi-Leblanc S; Germain C; Goehrs C; Grosskopf C; Labarthe B; Lechat P; Malciu C; Marquet P; Miceli-Richard C; Peyret O; Rattenbach R; de Saint-Exupéry E
    Therapie; 2020; 75(1):113-123. PubMed ID: 31948660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The publishing and patenting strategies of successful university spinoffs in the biopharmaceutical industry.
    Erden Z
    Drug Discov Today; 2017 Jan; 22(1):5-9. PubMed ID: 27634342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. University spin-offs: opportunity or challenge?
    Peng X
    Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301
    [No Abstract]   [Full Text] [Related]  

  • 12. University - industry collaborations: models, drivers and cultures.
    Ehrismann D; Patel D
    Swiss Med Wkly; 2015; 145():w14086. PubMed ID: 25658854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When is your experience valuable? Occupation-industry transitions and self-employment success.
    Koster S; Andersson M
    J Evol Econ; 2018; 28(2):265-286. PubMed ID: 29606804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Industry-university collaborations: a necessity for the future.
    Davies RM
    J Dent; 1996; 24(1-2):3-5. PubMed ID: 8636489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
    Germann PG; Schuhmacher A; Harrison J; Law R; Haug K; Wong G
    Hum Genomics; 2013 Mar; 7(1):5. PubMed ID: 23496921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The motivations, institutions and organization of university-industry collaborations in the Netherlands.
    Bodas Freitas IM; Verspagen B
    J Evol Econ; 2017; 27(3):379-412. PubMed ID: 28736486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project.
    Edmunds LD; Gluderer S; Ovseiko PV; Kamerling R; Ton J; Vis L; Jenni M; Tutton G; Lawton-Smith H; Nadabán MV; Rab M; Rees J; Anson J; Rushforth AD; Allen M; Buchan AM; Vendrell M; Casta A; Mehes G; Hogendoorn PCW; Hafen E; Hassan AB
    Health Res Policy Syst; 2019 Jan; 17(1):10. PubMed ID: 30691504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.
    Crager SE; Guillen E; Price M
    Am J Law Med; 2009; 35(2-3):253-79. PubMed ID: 19697749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. University-Industry Collaboration in China and the USA: A Bibliometric Comparison.
    Zhou P; Tijssen R; Leydesdorff L
    PLoS One; 2016; 11(11):e0165277. PubMed ID: 27832084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic Aspects of Industrial Biotechnology.
    Festel G
    Adv Biochem Eng Biotechnol; 2020; 173():53-74. PubMed ID: 30046916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.